Browse > Article
http://dx.doi.org/10.4062/biomolther.2015.176

Trichostatin A Protects Liver against Septic Injury through Inhibiting Toll-Like Receptor Signaling  

Kim, So-Jin (School of Pharmacy, Sungkyunkwan University)
Park, Jin-Sook (School of Pharmacy, Sungkyunkwan University)
Lee, Do-Won (School of Pharmacy, Sungkyunkwan University)
Lee, Sun-Mee (School of Pharmacy, Sungkyunkwan University)
Publication Information
Biomolecules & Therapeutics / v.24, no.4, 2016 , pp. 387-394 More about this Journal
Abstract
Sepsis, a serious clinical problem, is characterized by a systemic inflammatory response to infection and leads to organ failure. Toll-like receptor (TLR) signaling is intimately implicated in hyper-inflammatory responses and tissue injury during sepsis. Histone deacetylase (HDAC) inhibitors have been reported to exhibit anti-inflammatory properties. The aim of this study was to investigate the hepatoprotective mechanisms of trichostatin A (TSA), a HDAC inhibitor, associated with TLR signaling pathway during sepsis. The anti-inflammatory properties of TSA were assayed in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. Polymicrobial sepsis was induced in mice by cecal ligation and puncture (CLP), a clinically relevant model of sepsis. The mice were intraperitoneally received TSA (1, 2 or 5 mg/kg) 30 min before CLP. The serum and liver samples were collected 6 and 24-h after CLP. TSA inhibited the increased production of tumor necrosis factor (TNF)-${\alpha}$ and interleukin (IL)-6 in LPS-stimulated RAW264.7 cells. TSA improved sepsis-induced mortality, attenuated liver injury and decreased serum TNF-${\alpha}$ and IL-6 levels. CLP increased the levels of TLR4, TLR2 and myeloid differentiation primary response protein 88 (MyD88) protein expression and association of MyD88 with TLR4 and TLR2, which were attenuated by TSA. CLP increased nuclear translocation of nuclear factor kappa B and decreased cytosolic inhibitor of kappa B ($I{\kappa}B$) protein expression, which were attenuated by TSA. Moreover, CLP decreased acetylation of $I{\kappa}B$ kinase (IKK) and increased association of IKK with $I{\kappa}B$ and TSA attenuated these alterations. Our findings suggest that TSA attenuates liver injury by inhibiting TLR-mediated inflammatory response during sepsis.
Keywords
Histone deacetylase inhibitor; Nuclear factor kappa B; Sepsis; Toll-like receptor; Trichostatin A;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Abraham, E. (2003) Nuclear factor-${\kappa}B$ and its role in sepsis-associated organ failure. J. Infect. Dis. 187 Suppl 2, S364-S369.   DOI
2 Baldwin, A. S. Jr. (1996) The NF-${\kappa}B$ and $I{\kappa}B$ proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.   DOI
3 Beg, A. A., Finco, T. S., Nantermet, P. V. and Baldwin, A. S. Jr. (1993) Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of $I{\kappa}B{\alpha}$: a mechanism for NF-${\kappa}B$ activation. Mol. Cell. Biol. 13, 3301-3310.   DOI
4 Bergt, S., Wagner, N. M., Heidrich, M., Butschkau, A., Noldge-Schomburg, G. E., Vollmar, B. and Roesner, J. P. (2013) Hydrocortisone reduces the beneficial effects of toll-like receptor 2 deficiency on survival in a mouse model of polymicrobial sepsis. Shock 40, 414-419.   DOI
5 Bone, R. C. (1991) The pathogenesis of sepsis. Ann. Intern. Med. 115, 457-469.   DOI
6 Chakravortty, D., Koide, N., Kato, Y., Sugiyama, T., Mu, M. M., Yoshida, T. and Yokochi, T. (2000) The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells. J. Endotoxin Res. 6, 243-247.   DOI
7 Chaudry, I. H., Wichterman, K. A. and Baue, A. E. (1979) Effect of sepsis on tissue adenine nucleotide levels. Surgery 85, 205-211.
8 Chen, L. F., Mu, Y. and Greene, W. C. (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-${\kappa}B$. EMBOJ. 21, 6539-6548.   DOI
9 Chen, Y. R., Wang, X., Templeton, D., Davis, R. J. and Tan, T. H. (1996) The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and ${\gamma}$ radiation. J. Biol. Chem. 271, 31929-31936.   DOI
10 Choi, J. H., Oh, S. W., Kang, M. S., Kwon, H. J., Oh, G. T. and Kim, D. Y. (2005) Trichostatin A attenuates airway inflammation in mouse asthma model. Clin. Exp. Allergy 35, 89-96.   DOI
11 Johnstone, R. W. (2002) Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1, 287-299.   DOI
12 Ehrentraut, S., Lohner, R., Schwederski, M., Ehrentraut, H., Boehm, O., Noga, S., Langhoff, P., Baumgarten, G., Meyer, R. and Knuefermann, P. (2011) In vivo Toll-like receptor 4 antagonism restores cardiac function during endotoxemia. Shock 36, 613-620.   DOI
13 Finkelstein, R. A., Li, Y., Liu, B., Shuja, F., Fukudome, E., Velmahos, G. C., deMoya M. and Alam, H. B. (2010) Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock. J. Surg. Res. 163, 146-154.   DOI
14 Hebert, P. C., Drummond, A. J., Singer, J., Bernard, G. R. and Russell, J. A. (1993) A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 104, 230-235.   DOI
15 Kawai, T., Adachi, O., Ogawa, T., Takeda, K. and Akira, S. (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122.   DOI
16 Kim, M. S., Kwon, H. J., Lee, Y. M., Baek, J. H., Jang, J. E., Lee, S. W., Moon, E. J., Kim, H. S., Lee, S. K., Chung, H. Y., Kim, C. W. and Kim, K. W. (2001) Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7, 437-443.   DOI
17 Lagu, T., Rothberg, M. B., Shieh, M. S., Pekow, P. S., Steingrub, J. S. and Lindenauer, P. K. (2012) Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit. Care Med. 40, 754-761.   DOI
18 Li, Y. and Alam, H. B. (2011) Modulation of acetylation: creating a prosurvival and anti-inflammatory phenotype in lethal hemorrhagic and septic shock. J. Biomed. Biotechnol. 2011, 523481.
19 Mittal, R., Peak-Chew, S. Y. and McMahon, H. T. (2006) Acetylation of MEK2 and $I{\kappa}B$ kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc. Natl. Acad. Sci. U.S.A. 103, 18574-18579.   DOI
20 Luhrs, H., Gerke, T., Schauber, J., Dusel, G., Melcher, R., Scheppach, W. and Menzel, T. (2001) Cytokine-activated degradation of inhibitory ${\kappa}B$ protein a is inhibited by the short-chain fatty acid butyrate. Int. J. Colorectal Dis. 16, 195-201.   DOI
21 Nasu, Y., Nishida, K., Miyazawa, S., Komiyama, T., Kadota, Y., Abe, N., Yoshida, A., Hirohata, S., Ohtsuka, A. and Ozaki, T. (2008) Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarthr. Cartil. 16, 723-732.   DOI
22 Nesseler, N., Launey, Y., Aninat, C., Morel, F., Malledant, Y. and Seguin, P. (2012) Clinical review: The liver in sepsis. Crit. Care 16, 235.   DOI
23 Pan, L. N., Lu, J. and Huang, B. (2007) HDAC inhibitors: a potential new category of anti-tumor agents. Cell. Mol. Immunol. 4, 337-343.
24 Riedemann, N. C., Guo, R. F. and Ward, P. A. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9, 517-524.   DOI
25 Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., Ding, X. C., Chanson, A. L., Reymond, M. K., Miconnet, I., Schrenzel, J., Francois, P. and Calandra, T. (2011) Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 117, 1205-1217.   DOI
26 Sha, T., Iizawa, Y. and Ii, M. (2011) Combination of imipenem and TAK-242, a Toll-like receptor 4 signal transduction inhibitor, improves survival in a murine model of polymicrobial sepsis. Shock 35, 205-209.   DOI
27 Tong, X., Yin, L. and Giardina, C. (2004) Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition. Biochem. Biophys. Res. Commun. 317, 463-471.   DOI
28 Singhal, S., Alulen, M. W., McAnnally, J. R., Smith, K. S., Donnelly, J. P. and Wang, H. E. (2013) National estimates of emergency department visits for pediatric severe sepsis in the United States. PeerJ 1, e79.   DOI
29 Takala, A., Nupponen, I., Kylanpaa-Back, M. L. and Repo, H. (2002) Markers of inflammation in sepsis. Ann. Med. 34, 614-623.   DOI
30 Takashima, K., Matsunaga, N., Yoshimatsu, M., Hazeki, K., Kaisho, T., Uekata, M., Hazeki, O., Akira, S., Iizawa, Y. and Ii M. (2009) Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model. Br. J. Pharmacol. 157, 1250-1262.   DOI
31 Toscano, M. G., Ganea, D. and Gamero, A. M. (2011) Cecal ligation puncture procedure. J. Vis. Exp. 2860.
32 Williams, D. L., Ha, T., Li, C., Kalbfleisch, J. H., Schweitzer, J., Vogt, W. and Browder, I. W. (2003) Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit. Care Med. 31, 1808-1818.   DOI
33 Wu, J. and Grunstein, M. (2000) 25 years after the nucleosome model:chromatin modifications. Trends Biochem. Sci. 25, 619-623.   DOI
34 Zhang, L., Jin, S., Wang, C., Jiang, R. and Wan, J. (2010) Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis. World J. Surg. 34, 1676-1683.   DOI
35 Zhao, T., Li, Y., Liu, B., Liu, Z., Chong, W., Duan, X., Deperalta, D. K., Velmahos, G. C. and Alam, H. B. (2013) Novel pharmacologic treatment attenuates septic shock and improves long-term survival. Surgery 154, 206-213.   DOI
36 Zhang, L., Wan, J., Jiang, R., Wang, W., Deng, H., Shen, Y., Zheng, W. and Wang, Y. (2009) Protective effects of trichostatin A on liver injury in septic mice. Hepatol. Res. 39, 931-938.   DOI